Cabaletta Bio (CABA) Current Assets (2018 - 2025)

Cabaletta Bio has reported Current Assets for 8 years, with the latest figure at $138.9 million in Q4 2025.

• For the quarter ending Q4 2025, Current Assets fell 16.68% year-over-year to $138.9 million; the trailing twelve-month figure through Dec 2025 stood at $138.9 million (down 16.68% YoY), and the FY2025 full-year result was $138.9 million, down 16.68% from the prior year.
• Current Assets for Q4 2025 stood at $138.9 million, down from $164.6 million in the prior quarter.
• The five-year high for Current Assets was $244.5 million in Q4 2023, with the low at $88.2 million in Q3 2022.
• Average Current Assets over 5 years is $148.5 million, with a median of $136.7 million recorded in 2025.
• Year-over-year, Current Assets soared 137.62% in 2024 and sank 40.83% in 2025.
• Tracing CABA's Current Assets over 5 years: stood at $124.5 million in 2021, then retreated by 12.61% to $108.8 million in 2022, then jumped by 124.64% to $244.5 million in 2023, then tumbled by 31.83% to $166.7 million in 2024, then declined by 16.68% to $138.9 million in 2025.
• The last three Current Assets figures came in at $138.9 million (Q4 2025), $164.6 million (Q3 2025), and $198.4 million (Q2 2025), per Business Quant data.

Peer Comparison